Johnson Matthey (OTCMKTS:JMPLY)‘s stock had its “sell” rating reissued by equities researchers at UBS Group in a note issued to investors on Wednesday, The Fly reports.
Several other analysts have also issued reports on the company. Morgan Stanley restated an “overweight” rating on shares of Johnson Matthey in a research note on Friday, February 5th. Barclays restated an “underweight” rating on shares of Johnson Matthey in a research note on Wednesday, March 24th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Johnson Matthey in a research note on Tuesday, March 2nd. Zacks Investment Research upgraded Johnson Matthey from a “hold” rating to a “buy” rating and set a $95.00 price objective on the stock in a research note on Wednesday, April 7th. Finally, Credit Suisse Group restated an “outperform” rating on shares of Johnson Matthey in a research note on Wednesday, March 10th. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $95.00.
OTCMKTS:JMPLY opened at $89.15 on Wednesday. The stock’s 50 day moving average price is $86.99 and its two-hundred day moving average price is $73.46. The firm has a market capitalization of $8.63 billion, a price-to-earnings ratio of 17.58, a P/E/G ratio of 6.11 and a beta of 1.58. Johnson Matthey has a 12-month low of $44.21 and a 12-month high of $94.45.
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Article: Diluted Earnings Per Share
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.